Protective Effect of Atopic Dermatitis on Serum Lipid Levels
The relationship between atopic disease and serum lipid levels is investigated.
Dyslipidemia
Pfizer Ends Development of Vupanorsen Over Disappointing Results, Safety Issues
The decision was made based on data from a phase 2b study that evaluated vupanorsen in statin-treated patients with dyslipidemia.
Novel Omega-3 Krill Oil Agent Safe, Decreases Triglycerides in Hypertriglyceridemia
Researchers investigated the efficacy of a new drug containing a naturally derived krill oil mixture for treatment of severe hypertriglyceridemia.
The Need to Simplify Lipoprotein(a) Testing Guidelines: Test Everyone
Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.
Leqvio Approved as Twice-Yearly Injection to Lower LDL-C in High-Risk Patients
The approval was based on data from the ORION-9, ORION-10, and ORION-11 trials that evaluated Leqvio in patients 18 years of age and older with HeFH or clinical ASCVD.
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Cholestene, a dietary supplement marketed for cholesterol management, has been found to contain a hidden drug ingredient, according to the Food and Drug Administration. Based on laboratory analysis, the product, which is sold on various websites and in some retail stores, has been found to contain lovastatin, an HMG-CoA reductase inhibitor (statin). Consuming a supplement…
HOPE-3 Trial: Lasting Effect of Rosuvastatin Prevents Major Cardiovascular Events
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
Carotid Plaque Instability Risk Higher in Women With Metabolic Syndrome, Hypertriglyceridemia
This study aimed to assess the effects of the various elements of metabolic syndrome on carotid plaque destabilization.
Case Series: Insulin Infusions for Severe Hypertriglyceridemia With COVID-19
Findings of the review showed that continuous insulin infusion, coupled with standard oral lipid lowering therapies, successfully treated the hypertriglyceridemia.
Managing the Interplay of Familial Hypercholesterolemia and COVID-19
About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...